146 related articles for article (PubMed ID: 8993838)
1. Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways.
Giandomenico V; Lancillotti F; Fiorucci G; Percario ZA; Rivabene R; Malorni W; Affabris E; Romeo G
Cell Growth Differ; 1997 Jan; 8(1):91-100. PubMed ID: 8993838
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.
Giandomenico V; Vaccari G; Fiorucci G; Percario Z; Vannuchi S; Matarrese P; Malorni W; Romeo G; Affabris GR
Eur Cytokine Netw; 1998 Dec; 9(4):619-31. PubMed ID: 9889406
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid is able to induce interferon regulatory factor 1 in squamous carcinoma cells via a STAT-1 independent signalling pathway.
Percario ZA; Giandomenico V; Fiorucci G; Chiantore MV; Vannucchi S; Hiscott J; Affabris E; Romeo G
Cell Growth Differ; 1999 Apr; 10(4):263-70. PubMed ID: 10319996
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
Lancillotti F; Giandomenico V; Affabris E; Fiorucci G; Romeo G; Rossi GB
Cancer Res; 1995 Jul; 55(14):3158-64. PubMed ID: 7606736
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid and interferon-alpha effects on cell growth and differentiation in cervical carcinoma cell lines.
Yokoyama M; Nakao Y; Iwasaka T; Pater A; Sugimori H
Obstet Gynecol; 2001 Aug; 98(2):332-40. PubMed ID: 11506854
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
[TBL] [Abstract][Full Text] [Related]
7. Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells.
Arany I; Whitehead WE; Grattendick KJ; Ember IA; Tyring SK
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1102-6. PubMed ID: 12204966
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: correlation with tissue transglutaminase.
Chiantore MV; Giandomenico V; De Luca LM
Biochem Biophys Res Commun; 1999 Jan; 254(3):636-41. PubMed ID: 9920792
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis by all-trans retinoic acid in the human myeloma cell line RPMI 8226 and negative regulation of some of its typical morphological features by dexamethasone.
Lefebvre O; Wouters D; Méreau-Richard C; Facon T; Zandecki M; Formstecher P; Belin MT
Cell Death Differ; 1999 May; 6(5):433-44. PubMed ID: 10381637
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.
Vannucchi S; Percario ZA; Chiantore MV; Matarrese P; Chelbi-Alix MK; Fagioli M; Pelicci PG; Malorni W; Fiorucci G; Romeo G; Affabris E
Oncogene; 2000 Oct; 19(44):5041-53. PubMed ID: 11042692
[TBL] [Abstract][Full Text] [Related]
11. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines.
Zou CP; Clifford JL; Xu XC; Sacks PG; Chambon P; Hong WK; Lotan R
Cancer Res; 1994 Oct; 54(20):5479-87. PubMed ID: 7522960
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53.
Um SJ; Kim EJ; Hwang ES; Kim SJ; Namkoong SE; Park JS
Int J Cancer; 2000 Feb; 85(3):416-23. PubMed ID: 10652435
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative activity of interferon alpha and retinoic acid in SiHa carcinoma cells: the role of cell adhesion.
Matarrese P; Giandomenico V; Fiorucci G; Rivabene R; Straface E; Romeo G; Affabris E; Malorni W
Int J Cancer; 1998 May; 76(4):531-40. PubMed ID: 9590130
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha and all-trans-retinoic acid reversibly inhibit the in vitro proliferation of cell lines derived from cervical cancers.
Massad LS; Turyk ME; Bitterman P; Wilbanks GD
Gynecol Oncol; 1996 Mar; 60(3):428-34. PubMed ID: 8774652
[TBL] [Abstract][Full Text] [Related]
15. Identification of the eukaryotic initiation factor 5A as a retinoic acid-stimulated cellular binding partner for tissue transglutaminase II.
Singh US; Li Q; Cerione R
J Biol Chem; 1998 Jan; 273(4):1946-50. PubMed ID: 9442029
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid.
Jetten AM; Kim JS; Sacks PG; Rearick JI; Lotan D; Hong WK; Lotan R
Int J Cancer; 1990 Jan; 45(1):195-202. PubMed ID: 1967595
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.
Burke F; Smith PD; Crompton MR; Upton C; Balkwill FR
Br J Cancer; 1999 Jun; 80(8):1236-44. PubMed ID: 10376977
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells.
Arany I; Whitehead WE; Ember IA; Tyring SK
Anticancer Res; 2003; 23(1A):495-7. PubMed ID: 12680256
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human acute promyelocytic leukemia NB-4 cells by interferons and all-trans retinoic acid: trans-modulation of inducible gene expression pathways.
Kumar R; Korutla L
Anticancer Res; 1995; 15(2):353-60. PubMed ID: 7763006
[TBL] [Abstract][Full Text] [Related]
20. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.
Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R
Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
